Quantcast

Latest Artificial heart Stories

2010-02-12 16:27:00

HOUSTON, Feb. 12 /PRNewswire/ -- The wait is over for 16-year-old Francesco "Frank" De Santiago. On January 29, De Santiago received a donor heart in a successful nine-hour transplant operation at Texas Children's Heart Center. De Santiago made medical history last October for being the first child ever discharged from a pediatric hospital with an implanted mechanical heart pump, or intracorporeal ventricular assist device (VAD). Until then, pediatric patients with mechanical heart...

2010-01-20 12:34:00

Device Provides Support for Those Who Are Not Acceptable Transplant Candidates SILVER SPRING, Md., Jan. 20 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the HeartMate II, a continuous-flow, left ventricular assist system as a support for severe heart failure patients who are not acceptable candidates for heart transplantation. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) The HeartMate II is already FDA-approved for use in patients...

2009-12-15 05:30:00

MINNEAPOLIS, Dec. 15 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced that the United States Patent and Trademark Office has issued patent number 7,594,974 regarding a novel method of cutting tissue materials for use in implantable devices. (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO) The patent, entitled "Method of Cutting Material for Use in Implantable...

2009-12-01 17:16:00

NEW YORK, Dec. 1 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Artificial Organs - Worldwide Market Challenges & Opportunities http://www.reportlinker.com/p0164217/Artificial-Organs---Worldwide-Market-Challenges--Opportunities.html With decades of research and advances in technology, artificial organs have become the viable alternative to effectively address donor organ shortage problem. Besides sustaining life and...

2009-11-17 12:03:43

A new generation of implanted devices that help a failing heart function properly is significantly more effective than the previous version, making these new devices an appropriate permanent therapy for many of the more than 5 million Americans who suffer from heart failure. A research team led by a University of Louisville cardiac surgeon published data to support these conclusions in the November 17, 2009 Online First edition of the New England Journal of Medicine. The results were...

2009-11-17 07:00:00

Study highlights: -- Continuous flow heart pump improved survival better than pulsating pump for heart failure patients ineligible for transplant. -- The new, continuous flow left ventricular assist device is smaller, quieter and more durable than pulsating models. ORLANDO, Fla., Nov. 17 /PRNewswire-USNewswire/ -- A new, continuous flow heart pump, or left ventricular assist device (LVAD), delivered better two-year survival in advanced heart failure patients than the current pulsatile...

2009-11-11 18:09:00

Teen enjoys normal activities outside of hospital while awaiting donor heart Texas Children's Hospital is the nation's first pediatric hospital to discharge a child while on an intracorporeal ventricular assist device (VAD), a feat previously accomplished only at adult institutions. The patient, 16-year-old Francisco "Frank" De Santiago, who was implanted with a mechanical heart pump called the HeartMate II on May 19, 2009, was discharged on Oct. 29, 2009. "This is a promising next step for...

2009-11-10 12:48:00

BERLIN, November 10 /PRNewswire/ -- The 500th patient to receive an INCOR(R) ventricular assist device was implanted on 20 October 2009 at the German Heart Institute Berlin. The 39-year-old male patient was suffering from dilative cardiomyopathy, a disease that causes the heart to enlarge and the heart muscle to weaken to the extent that it cannot provide enough blood flow through the body. The cardiomyopathy progressed to a stage where conventional treatment was no longer...

2009-10-27 13:56:49

UT Southwestern Medical Center patient Michael LeBlanc, 40, is the first in North Texas to receive the newest generation of a mechanical device designed to improve heart function. It will be his lifeline while he awaits a heart transplant. Called a left-ventricular assist device (LVAD), its purpose is to help a patient's weakened heart pump blood throughout the body. For Mr. LeBlanc, it will help his ailing heart continue to pump until the Irving resident receives a new heart. UT Southwestern...

2009-10-05 15:00:00

FRAMINGHAM, Mass. and SYDNEY, Oct. 5 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to expand the number of clinical sites participating in its U.S. bridge-to-transplant trial, known as the ADVANCE trial. Pursuant to the FDA approval, HeartWare will be permitted to enroll a total of 40 clinical sites for the purposes of evaluating the Company's Ventricular...


Latest Artificial heart Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »
Word of the Day
snash
  • To talk saucily.
  • Insolent, opprobrious language; impertinent abuse.
This word is Scots in origin and probably imitative.